PMID- 20511533
OWN - NLM
STAT- MEDLINE
DCOM- 20100915
LR  - 20180404
IS  - 1554-6063 (Electronic)
IS  - 0145-7217 (Linking)
VI  - 36 Suppl 2
DP  - 2010 May-Jun
TI  - A new look at established therapies: practical tools for optimizing insulin use.
PG  - 26S-38S; quiz 39S-40S
LID - 10.1177/0145721710369637 [doi]
AB  - PURPOSE: Current evidence shows early initiation of insulin therapy in type 2 
      diabetes mellitus (T2DM) improves glycemic control, responsiveness to subsequent 
      oral antidiabetic therapies, beta-cell function, and possible cardiovascular 
      outcomes. The American Diabetes Association (ADA)/European Association for the 
      Study of Diabetes (EASD) 2008 algorithm introduces insulin therapy earlier in the 
      treatment of T2DM with prompt intensification to achieve therapeutic goals. Agent 
      selection and insulin regimens are based on patient A1C levels and willingness to 
      monitor blood glucose, use of previous medications, blood glucose patterns, diet, 
      and lifestyle. Practical considerations offered for diabetes educators and 
      clinicians include creating strategies for early initiation of insulin, 
      addressing patients' psychosocial barriers and quality of life concerns, 
      understanding pharmacokinetic properties of insulin formulations, selecting 
      appropriate therapy and patient-based regimens, and intensifying therapy to 
      achieve glycemic control. CONCLUSIONS: Diabetes education, including intentional 
      curriculum design, for patients with T2DM who are initiating or intensifying 
      insulin therapy, addresses patient barriers to care, reduces the burden of 
      treatment, improves adherence to treatment protocols, and helps optimize clinical 
      outcomes.
FAU - Gavin, James R 3rd
AU  - Gavin JR 3rd
AD  - Healing Our Village, Inc, and Emory University School of Medicine, Atlanta, GA 
      (Dr Gavin)
FAU - Peragallo-Dittko, Virginia
AU  - Peragallo-Dittko V
AD  - The Diabetes Education Center, Winthrop-University Hospital, Mineola, NY (Ms 
      Peragallo-Dittko)
FAU - Rodgers, Philip T
AU  - Rodgers PT
AD  - The University of North Carolina Eshelman School of Pharmacy, Duke University 
      Hospital, and Duke Area Health Education Centers, Durham, NC (Mr Rodgers)
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Diabetes Educ
JT  - The Diabetes educator
JID - 7701401
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 0 (Sulfonylurea Compounds)
RN  - 9100L32L2N (Metformin)
MH  - Algorithms
MH  - Diabetes Mellitus/*drug therapy/rehabilitation
MH  - Humans
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Insulin/*therapeutic use
MH  - Metformin/therapeutic use
MH  - Patient Education as Topic
MH  - Reproducibility of Results
MH  - Sulfonylurea Compounds/therapeutic use
EDAT- 2010/06/04 06:00
MHDA- 2010/09/16 06:00
CRDT- 2010/06/01 06:00
PHST- 2010/06/01 06:00 [entrez]
PHST- 2010/06/04 06:00 [pubmed]
PHST- 2010/09/16 06:00 [medline]
AID - 36/2_suppl/26S [pii]
AID - 10.1177/0145721710369637 [doi]
PST - ppublish
SO  - Diabetes Educ. 2010 May-Jun;36 Suppl 2:26S-38S; quiz 39S-40S. doi: 
      10.1177/0145721710369637.